| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_4c6a5e46237429bffa3dd79e3e606901 |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P1-14
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-0019
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K38-25
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K38-08 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P1-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K38-08
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P21-00 |
| filingDate |
2017-05-12-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_ed11c2344553bb675a1aebe9a2201ef4
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_68d8c9a55f2486870a9710ae9defe2c4
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_64cb772c9c82c1494a9c1100cae4d240 |
| publicationDate |
2017-11-16-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
WO-2017197328-A1 |
| titleOfInvention |
Treatment of enteral feeding intolerance and muscle wasting with relamorelin |
| abstract |
Enteral Feeding Intolerance (EFI) and conditions associated with loss of muscle mass can be efficaciously treated by administration of therapeutically effective doses of relamorelin every 8 hours (three times a day). Therapeutic benefit can be obtained from single and consecutive daily dosing, including for periods of up to a week or longer. |
| isCitedBy |
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2022206587-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2021067819-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-10092621-B2 |
| priorityDate |
2016-05-12-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |